Previous 10 | Next 10 |
Shares of Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at $94.97, eclipsing its 52-week high. This new high was reached on below average trading volume as 748,000 shares traded hands, while the average 30-day volume is approximately 1.2 million shares. Arena Pharmaceuticals is a...
Arena Pharmaceuticals press release (NASDAQ:ARNA): Q4 GAAP EPS of -$2.54 misses by $0.31. Cash, cash equivalents and marketable securities were $0.7B at December 31, 2021 as compared to $1.1B at December 31, 2020 For further details see: Arena Pharmaceuticals GAAP EPS of -$2.54 misses b...
– Phase 3 ELEVATE UC 52 and 12 on course for Q1 2022 topline data readout Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) today provided a corporate update and reported financial results for the fourth quarter and full year ended December 31, 2021. Key Program &...
With the legalisation of marijuana in most states in the US and North America, the weed industry is really heating up. As an investor, you want to be part of growth industries, and this is one of them. So, what are some of the top weed stocks you should be looking at in 2022? Here is a ...
Form 13F filings show fund managers' top merger arbitrage stocks. Top M&A stocks of the 30 funds I follow. Nuance Communications the top pick for the 2nd straight quarter. For further details see: Top Merger Stocks Held By Fund Managers, Mid-Q1 2022
In this clip from "The Pharma & Biotech Show" on Motley Fool Live , recorded on Feb. 2 , Motley Fool contributors Keith Speights and Brian Orelli explain why the news of a discontinued drug from the pharmaceutical giant hasn't shaken investors. Keith Speights: Pf...
Lockheed Martin terminates deal with Aerojet Rocketdyne. On January 25, 2022, the Federal Trade Commission sued to block the deal. Frontier Group Holdings to acquire Spirit Airlines. For further details see: Merger Arbitrage Mondays: Lockheed Martin Scraps Plans ...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $94.24. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.4 million shares. In the past 52 weeks, shares of Arena Pharmaceuticals Inc. have traded betw...
Arena Pharmaceuticals, Inc. (Nasdaq: ARNA) will release its fourth quarter and full-year 2021 financial results and provide a corporate update on Wednesday, February 23, 2022, after the close of the U.S. financial markets. About Arena Pharmaceuticals ARENA Pharmaceutic...
Biotechs struggled in 2021 as indexes lagged the broader market. So far in 2022, biotechs have dropped sharply as interest rate uncertainty has created a risk-off market. A rising interest rate environment remains the biggest risk for biotechs. With the S&P 500 biotech index h...
News, Short Squeeze, Breakout and More Instantly...
Arena Pharmaceuticals Inc. Company Name:
ARNA Stock Symbol:
NASDAQ Market:
Arena Pharmaceuticals Inc. Website:
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded at a new 52-week high today of $99.95. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.2 million shares. Arena Pharmaceuticals is a biotechnology company targeting G-protein-couple...
Arena Pharmaceuticals Inc. (NASDAQ:ARNA) traded today at a new 52-week high of $98.57. So far today approximately 748,000 shares have been exchanged, as compared to an average 30-day volume of 1.1 million shares. Over the past year, Arena Pharmaceuticals Inc. has traded in a range of $45...